Cited 5 times in
Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.